Johnson & Johnson logo

Latest headlines

Johnson & Johnson News

The latest Johnson & Johnson (JNJ) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these JNJ headlines next to the live Johnson & Johnson Fear and Greed Index.

Latest Johnson & Johnson Headlines30

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

zacks.com · Aug 27, 2026

China approves J&J's oral psoriasis pill, says drugmaker

reuters.com · Aug 27, 2026

Johnson & Johnson Just Got a Big FDA Win

fool.com · Aug 27, 2026

Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

zacks.com · Aug 26, 2026

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

fool.com · Aug 26, 2026

Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus

fool.com · Aug 26, 2026

J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA

zacks.com · Aug 25, 2026

J&J's First-In-Disease Approval Barely Moves a $666 Billion Stock

gurufocus.com · Aug 25, 2026

Bank of Montreal beats earnings estimates on US banking strength

proactiveinvestors.com · Aug 25, 2026

Nasdaq rises as Wall Street gets relief from falling yields

proactiveinvestors.com · Aug 25, 2026

Dick's Sporting Goods stock craters on earnings miss

proactiveinvestors.com · Aug 25, 2026

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients

prnewswire.com · Aug 24, 2026

US FDA expands approval for J&J's drug for rare blood disorder

reuters.com · Aug 24, 2026

Q2 Earnings Season Winds Down: 3 Companies That Broke Records

zacks.com · Aug 24, 2026

Johnson & Johnson Rises 1.3% as Investors Seek Stability

gurufocus.com · Aug 24, 2026

Louisiana Jury Issues $10 Million Verdict in Talc-Related Mesothelioma Case Against Johnson & Johnson

businesswire.com · Aug 24, 2026

J&J's Strong Pipeline Momentum Offers Multiple Growth Catalysts Ahead

zacks.com · Aug 24, 2026

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

fool.com · Aug 23, 2026

Johnson & Johnson: Buy IMAAVY Label Expansion First And Continued CAPLYTA Sales Push

seekingalpha.com · Aug 22, 2026

3 Dividend Stocks to Buy and Hold for the Next 5 Years

fool.com · Aug 22, 2026

Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update

zacks.com · Aug 21, 2026

Merck vs. J&J: Which Healthcare Giant Should Investors Choose?

zacks.com · Aug 21, 2026

Johnson & Johnson (JNJ) Registers a Bigger Fall Than the Market: Important Facts to Note

zacks.com · Aug 20, 2026

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

fool.com · Aug 20, 2026

Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future

fool.com · Aug 20, 2026

Warren Buffett Thinks Investors Are "Gambling" and "Playing With Fire" Right Now. But Here Are 3 Safe Stocks Even the Oracle of Omaha Would Like.

fool.com · Aug 19, 2026

Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts Shares

gurufocus.com · Aug 18, 2026

Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets

fool.com · Aug 18, 2026

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

fool.com · Aug 18, 2026

J&J's New Growth Powerhouses: Immunology and Neuroscience

zacks.com · Aug 18, 2026

Why Is Johnson & Johnson Up or Down Today?

When Johnson & Johnson (JNJ) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a JNJ move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Johnson & Johnson is up or down today.

How Johnson & Johnson News Affects the Price

News does not move the Johnson & Johnson (JNJ) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Johnson & Johnson Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Johnson & Johnson trading volume. That is the chain to watch: headline, sentiment, volume, then the JNJ price.

Trade the Johnson & Johnson News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Johnson & Johnson trading volume spike on a big story, check the Johnson & Johnson price history for context, follow the live JNJ price, see the Johnson & Johnson price prediction, and read the Johnson & Johnson Fear and Greed Index for mood.

How do you feel about Johnson & Johnson?

1D

Frequently asked questions

Why is Johnson & Johnson up or down today?
Johnson & Johnson (JNJ) moves on news, and the headlines above are the fastest way to see what is driving JNJ today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Johnson & Johnson Fear and Greed Index and JNJ trading volume.
What is the latest Johnson & Johnson news?
The newest Johnson & Johnson (JNJ) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent JNJ news cycle in one place.
Where does Johnson & Johnson news come from?
We aggregate Johnson & Johnson (JNJ) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.
How often is Johnson & Johnson news updated?
Continuously. The Johnson & Johnson (JNJ) feed refreshes as new stories are published, so the headlines at the top are the freshest available.
How does Johnson & Johnson news relate to its Fear and Greed Index?
News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Johnson & Johnson Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.